** Medical devices maker Medtronic's shares MDT.N fall 5.7% to $87.49, set to snap a five-day winning streak
** Co posts Q3 sales of $2.07 bln for its surgical devices unit, missing analyst est of $2.13 bln, as per data compiled by LSEG
** Co says a change in buying patterns by its distributors in the U.S. hurt the unit, along with competitive pressures in the surgical staplers market
** MDT reports Q3 adj profit of $1.39/share, higher than analysts' estimates of $1.36/share
** Sales in co's diabetes unit rose 8.4% to $694 million in Q3, beating estimates of $681.8 million
** Co maintains 2025 forecast of $5.44 per share to $5.50 per share
** Stock has risen ~11% in the past 12 months
(Reporting by Padmanabhan Ananthan)
((Padmanabhan.Ananthan@thomsonreuters.com;))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.